FDA Inspection
Eurofins PROXY Laboratories B.V.Eurofins PROXY Laboratories B.V. – FDA Inspection, Sep 19, 2025
Record Details
This FDA Inspection record concerns Eurofins PROXY Laboratories B.V., with an inspection on September 19, 2025, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · b9470d13-8e8a-44f0-b78b-4102ed80ebd9
Inspection Facts
- Inspection number
- 1282304
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
4- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)(9)Control / Lab Operations Area
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eurofins PROXY Laboratories B.V.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 21, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eurofins PROXY Laboratories B.V.
- FDA Inspection 1272171 - 2022-07-01
- FDA Inspection 1124234 - 2019-08-21
- FDA Inspection 1028845 - 2017-09-07
- FDA Inspection 904889 - 2014-11-06
- FDA Inspection 750139 - 2011-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.